Cyclohexane

Cyclohexane

SCHEMBL1245819

C1CCCCC1.C1CCCCC1.CC(=O)CC1CCCCC1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.50
HPGD P15428 3/20 0.50
KMT2A Q03164 1/20 0.50
EPHX2 P34913 2/20 0.41
ALOX5 P09917 1/20 0.40
ADH1B P00325 1/20 0.39
ADH1C P00326 1/20 0.39
ADH1A P07327 1/20 0.39
ADH4 P08319 1/20 0.39
ADH7 P40394 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
P2RX7 Q99572 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368048 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
Cyclohexane SCHEMBL7088247 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
SCHEMBL31332587 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
SCHEMBL28568368 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
Cyclohexane SCHEMBL7091110 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
SCHEMBL363901 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
Cyclohexane SCHEMBL1245516 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
Cyclohexane SCHEMBL14673180 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
Cyclohexane SCHEMBL11035387 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5
SCHEMBL1228532 1.00 EPHX1 (0.50) EPHX1HPGDKMT2AEPHX2ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106188098-B A kind of hydridization cancer therapy drug and preparation method and application 广东工业大学 2017-11-03 CN disclosed
CN-106188098-A A kind of hydridization cancer therapy drug and preparation method and application 广东工业大学 2016-12-07 CN disclosed
EP-2668198-A1 FGF RECEPTOR-ACTIVATING 3-O-ALKYL OLIGOSACCHARIDES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2013-12-04 EP disclosed
WO-2012101605-A1 FGF RECEPTOR-ACTIVATING 3-O-ALKYL OLIGOSACCHARIDES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-08-02 WO disclosed
WO-2011018588-A2 FGF RECEPTOR-ACTIVATING N-ACYL OCTASACCHARIDES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-02-17 WO disclosed
US-4548936-A ANTICOAGULANTS, VASODILATORS, AND HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1985-10-22 US disclosed